Eddie Hickman

Stock Analyst at Guggenheim

(n/a)

# 864

Out of 4,479 analysts

6

Total ratings

n/a

Success rate

-34.94%

Average return

Main Sectors:

Top Industries:

2 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	OTLK Outlook Therapeutics	Upgrades: Buy	$40	$7.41	+439.81%	2	Jan 25, 2024
	TARS Tarsus Pharmaceuticals	Maintains: Buy	$46 → $49	$28.24	+73.51%	4	Sep 11, 2023

Outlook Therapeutics

Jan 25, 2024

Upgrades: Buy

Price Target: $40

Current: $7.41

Upside: +439.81%

Tarsus Pharmaceuticals

Sep 11, 2023

Maintains: Buy

Price Target: $46 → $49

Current: $28.24

Upside: +73.51%